Xometry After the Rally - Why I'm Still Buying and Where I Draw the Line

Hook and thesis

Xometry (XMTR) has surged roughly 157% off its 2025 lows to trade near $93.25 today, but the move is not purely speculative noise. The company is showing sustained revenue growth, improving margins on a non-GAAP basis in recent quarters, and it just completed a material $225 million follow-on at $85. That combination - growth plus fresh capital - is exactly the setup I want to buy from a tactical perspective.

My thesis is straightforward: this is a growth marketplace with sticky industrial demand, improving unit economics, and a balance sheet that was just strengthened by the equity raise. The market has already priced in a lot of optimism - market cap is about $5.15 billion - but the fundamentals and technical backdrop give me a workable risk-reward to add on weakness or in a structured nibble now. Below I lay out precise entry, stop, and target levels, time horizons (including how long I plan to hold), the catalysts I expect to drive the next leg higher, and the risks I am watching closely.

What Xometry does and why the market should care

Xometry runs an AI-powered industrial marketplace and owns Thomasnet, a well-known industrial sourcing platform. The core value prop is instant pricing and lead-time estimates for custom-manufactured parts, matched to a distributed network of factories that fill spare capacity. That matchmaking reduces procurement friction for buyers and gives suppliers higher utilization. Over time this can expand gross margins through pricing power, platform fees, and higher take-rates on software and services.

The market cares because industrial procurement is large and fragmented; digitizing even a small share is worth a lot. Xometry pairs data and AI to optimize allocation of manufacturing work across its network - a classic two-sided marketplace that benefits from network effects as more buyers and manufacturers join. Thomasnet expands visibility into the broader industrial funnel, providing cross-sell opportunities for advertising, marketing, and financial services.

Supporting fundamentals - the numbers

• Recent reported momentum: Q3 2025 GAAP revenue reached $180.7 million, up 28% year-over-year. Earlier in 2025 Q2 revenue was reported at $162.5 million, a 23% YoY increase. Those aren’t small, single-digit prints - they show multi-quarter top-line acceleration.
• Valuation snapshot: market capitalization is roughly $5.15 billion and enterprise value is about $5.46 billion. Price-to-sales is near 6.96x and price-to-book sits in the high teens (around 17-18x depending on source), reflecting a growth premium.
• Profitability: GAAP EPS remains negative with trailing EPS around -$0.94 per share, but management has shown improving non-GAAP results and raised guidance previously after quarters with better profitability metrics. Free cash flow most recently was slightly negative at -$10.86 million, which is consistent with growth mode but not an alarming burn rate relative to the capital raised.
• Balance sheet and liquidity: the company priced an underwritten public offering of 2,647,059 shares at $85.00 per share and raised approximately $225 million in gross proceeds. That offering, expected to close on 06/03/2026, meaningfully bolsters liquidity for working capital and growth investments.
• Short interest has meaningfully declined from north of 5.5 million shares in January to about 3.45 million shares as of the 05/29/2026 settlement - days-to-cover sits near 4.31. That reduction lowers the mechanical risk of a short squeeze unwind working against buyers and suggests a portion of the bearish positioning has been removed.

Technical and market structure context

• Price sits above the 10-day SMA ($85.46), 20-day SMA ($87.68) and comfortably above the 50-day SMA ($71.29), signaling a clear rally context. The 9-day EMA is about $87.60 while the 21-day EMA is near $84.90 - both below the current price of $93.25.
• Momentum indicators show some caution - RSI at 67 is getting toward overbought territory and MACD currently flags bearish momentum in the short term - but strong price support at the recent consolidation band near $80-$86 gives a logical area for stops.

Valuation framing

At a market cap roughly $5.15 billion and P/S near 7x, Xometry is priced like a high-growth SaaS/marketplace rather than a legacy industrial supplier. That premium is defendable if revenue growth continues in the 20-30% range and the company converts to positive free cash flow and expanding margins over the next several quarters. If growth slows materially or margin expansion stalls, the valuation will look stretched quickly - and that is the key watch.

Trade plan - exact entries, stops, and targets

I’m initiating a long with a primary entry at $92.00 and a stop loss at $80.00. My target is $110.00. That gives a clear risk-reward profile and respects both the recent offering price of $85 and the chart lows in the $75-$80 area.

How I intend to manage the trade: position size should be sized so the $12 risk (entry to stop) equals the predefined risk allocation for the trade (for many retail portfolios that will be 1-2% of account equity). I treat this primarily as a mid-term swing trade with the intention to reevaluate at the target or on a break of $80. If the stock reaches $110, I will either take profits or scale out and hold a smaller core if the revenue and margin story is intact for a move beyond $110 over 180 trading days.

Catalysts to drive the next leg

• Continued top-line acceleration in upcoming quarterly reports. The company has shown sequential revenue growth ($162.5M in Q2 2025, $180.7M in Q3 2025), and another beat would re-rate multiples higher.
• Further margin improvement or guidance hikes from management. Management has raised guidance historically after better-than-expected quarters; another similar event would remove valuation overhang.
• Monetization of Thomasnet and higher take-rates on services and advertising - incremental revenue streams reduce dependency on marketplace volumes alone.
• Reduced short interest and lower days-to-cover - as bearish positioning continues to unwind, the path of least resistance can be upward if fundamentals stay positive.

Risks and counterarguments

• Valuation is rich. At nearly 7x sales and a market cap above $5 billion, investor patience for execution is limited. If growth slips below high-teens percentages, the stock could reprice quickly.
• Profitability still fragile. GAAP EPS is negative (trailing about -$0.94), and free cash flow was recently negative. Continued quarterly cash burn or an earnings miss would be punished harshly.
• Macro industrial demand risk. Xometry’s business is tied to manufacturing activity. A broad slowdown in capex or cyclical weakness in industrial production could compress volumes and pricing.
• Dilution and supply-side pressure. The company just raised $225 million via an equity offering at $85. While that improves liquidity, it also increases float and could weigh on the stock if the market views it as a sign that organic cash generation is insufficient.
• Execution risk on Thomasnet integration. Thomasnet presents cross-sell opportunities, but failure to monetize it at scale could limit revenue diversification and leave Xometry dependent on marketplace volume growth alone.

Counterargument I respect

One reasonable opposing view: the $85 offering masked deteriorating cash generation, and the market is paying a premium for top-line growth that won’t translate to durable profits. If management cannot sustain margin expansion while scaling, multiples will compress and the stock could revisit the $50s or lower. That scenario is plausible and is precisely why I anchor my stop at $80 - a clear break below the offering price and the recent consolidation would invalidate my thesis.

What would change my mind

I will change my stance if any of the following happen: (1) management withdraws guidance or issues materially weaker guidance on the next earnings call; (2) revenue growth falls consistently below 15% YoY; (3) free cash flow turns meaningfully more negative without a credible plan to return to breakeven; or (4) the stock breaks and sustains below $80 on rising volume. Conversely, a sustained acceleration in revenue growth above 30% with visible margin expansion would make me more aggressive and extend the target beyond $110.

Conclusion

Xometry is not a low-volatility trade; it is a growth-platform name priced for continued execution. The recent $225 million raise at $85 reduces a key balance-sheet concern and gives management optionality to invest in growth and margin expansion. Combined with multi-quarter revenue acceleration and declining short interest, I am comfortable initiating a defined-risk long here with an entry at $92, stop at $80, and target at $110. Treat this as a mid-term swing position (45 trading days) that can be extended to a longer-term position (180 trading days) if upcoming quarters confirm the margin and revenue thesis.

Key watch items between now and the next quarterly report

• Monthly/quarterly cadence on active buyers and order volumes.
• Any commentary on Thomasnet monetization and cross-sell traction.
• Change in short interest and days-to-cover across settlements.
• Guidance changes on the next earnings call and management commentary about where the equity raise will be deployed.